AIKATERINI ANAGNOSTOU to United States
This is a "connection" page, showing publications AIKATERINI ANAGNOSTOU has written about United States.
Connection Strength
0.507
-
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2025 Jan; 155(1):62-69.e1.
Score: 0.071
-
Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report. J Allergy Clin Immunol Pract. 2023 08; 11(8):2330-2334.
Score: 0.064
-
Qualitative interviews to understand health care providers' experiences of prescribing licensed peanut oral immunotherapy. BMC Res Notes. 2022 Aug 08; 15(1):273.
Score: 0.061
-
Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy. Ann Allergy Asthma Immunol. 2020 08; 125(2):196-201.e1.
Score: 0.052
-
Development of peanut allergy despite early introduction: A real-world case series in the United States. Pediatr Allergy Immunol. 2020 07; 31(5):589-592.
Score: 0.052
-
Emerging triggers of food protein-induced enterocolitis syndrome: Lessons from a pediatric cohort of 74 children in the United States. Ann Allergy Asthma Immunol. 2019 04; 122(4):407-411.
Score: 0.048
-
Insights from 275 cases of childhood anaphylaxis in the United States. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1696-1699.e2.
Score: 0.047
-
Lupin: An emerging food allergen in the United States. Ann Allergy Asthma Immunol. 2019 01; 122(1):8-10.
Score: 0.047
-
A Health-Economic Analysis of Alpha-Gal Screening in the Asymptomatic Patient to Prevent Fatal Anaphylaxis. J Allergy Clin Immunol Pract. 2026 Jul; 14(7):1638-1643.e4.
Score: 0.020
-
Insect Allergy: Barriers in Training and Practice-A Work Group Report of the AAAAI Anaphylaxis Committee. J Allergy Clin Immunol Pract. 2025 03; 13(3):501-510.
Score: 0.018
-
Asthma outcomes in pediatric patients with 30-day follow-up after an asthma hospitalization in a Medicaid-managed care program. J Asthma. 2023 09; 60(9):1734-1740.
Score: 0.016
-
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? J Allergy Clin Immunol. 2020 04; 145(4):1153-1156.
Score: 0.013